Endo, Inc. (OTCQX: NDOI) has reached a definitive agreement with MC2 Therapeutics to commercialize Wynzora® Cream in Canada ...

Endo, Inc. (OTCQX: NDOI) announced today that it has entered into a definitive agreement with MC2 Therapeutics ("MC2") to commercialize Wynzora® Cream (calcipotriene ...

Endo, Inc. (OTCQX: NDOI) announced today that it has entered into a definitive agreement with MC2 Therapeutics ("MC2") to commercialize Wynzora® Cream ...

Arcutis Biotherapeutics has returned an impressive +200% YTD, following the successful product launch of Zoryve. See why I rate ARQT stock as a Strong Buy.

One woman’s journey from receiving her diagnosis to finding a treatment that helps manage her chronic skin condition.

University of Copenhagen researchers have developed a prototype patch for treating plaque psoriasis, which may simplify ...

Both body creams and lotions hydrate skin, but they have a few key differences. The main is consistency. Here’s how to tell ...

ZORYVE cream 0.15% is the first once-daily, Food and Drug Administration (FDA)-approved topical treatment for mild to moderate atopic dermatitis ZORYVE, a next-generation topical phosphodiesterase-4 ...

Reviewed by Lexie CornerNov 13 2024 According to a study published in Biomaterials Advances, scientists at the University of ...

DelveInsight's Dermatological Drugs Market Insights report provides the current and forecast market analysis, individual ...